Allogeneic Hematopoietic Cell Transplantation in Septuagenarians

被引：1
作者：
Grunwald, Michael R. [1 ]
机构：
[1] Carolinas HealthCare Syst, Levine Canc Inst, Charlotte, NC 28204 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2013年 / 19卷 / 09期
关键词：
ACUTE MYELOID-LEUKEMIA; RISK MYELODYSPLASTIC SYNDROME; OLDER PATIENTS; RANDOMIZED-TRIAL; AGE; OUTCOMES; INTENSITY; MORTALITY; REGIMENS;
D O I：
10.1016/j.bbmt.2013.07.012
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1276 / 1278
页数：3
相关论文
共 22 条
  • [1] Optimal positioning of hematopoietic stem cell transplantation for older patients with myelodysplastic syndromes
    Abel, Gregory A.
    Koreth, John
    [J]. CURRENT OPINION IN HEMATOLOGY, 2013, 20 (02) : 150 - 156
  • [2] Age and acute myeloid leukemia
    Appelbaum, FR
    Gundacker, H
    Head, DR
    Slovak, ML
    Willman, CL
    Godwin, JE
    Anderson, JE
    Petersdorf, SH
    [J]. BLOOD, 2006, 107 (09) : 3481 - 3485
  • [3] Preparative Regimens and Ageism
    Appelbaum, Frederick R.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (10) : 1419 - 1420
  • [4] A disease risk index for patients undergoing allogeneic stem cell transplantation
    Armand, Philippe
    Gibson, Christopher J.
    Cutler, Corey
    Ho, Vincent T.
    Koreth, John
    Alyea, Edwin P.
    Ritz, Jerome
    Sorror, Mohamed L.
    Lee, Stephanie J.
    Deeg, H. Joachim
    Storer, Barry E.
    Appelbaum, Frederick R.
    Antin, Joseph H.
    Soiffer, Robert J.
    Kim, Haesook T.
    [J]. BLOOD, 2012, 120 (04) : 905 - 913
  • [5] Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation
    Artz, Andrew S.
    Pollyea, Daniel A.
    Kocherginsky, Masha
    Stock, Wendy
    Rich, Elizabeth
    Odenike, Olatoyosi
    Zimmerman, Todd
    Smith, Sonali
    Godley, Lucy
    Thirman, Michael
    Daugherty, Christopher
    Extermann, Martine
    Larson, Richard
    van Besien, Koen
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (09) : 954 - 964
  • [6] From Biology to Clinical Practice: Aging and Hematopoietic Cell Transplantation
    Artz, Andrew S.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (01) : S40 - S45
  • [7] Outcomes in Patients Age 70 or Older Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
    Brunner, Andrew M.
    Kim, Haesook T.
    Coughlin, Erin
    Alyea, Edwin P., III
    Armand, Philippe
    Ballen, Karen K.
    Cutler, Corey
    Dey, Bimalangshu R.
    Glotzbecker, Brett
    Koreth, John
    McAfee, Steven L.
    Spitzer, Thomas R.
    Soiffer, Robert J.
    Antin, Joseph H.
    Ho, Vincent T.
    Chen, Yi-Bin
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (09) : 1374 - 1380
  • [8] Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation for Myelodysplastic Syndrome or Acute Myeloid Leukemia
    Chen, Yi-Bin
    Coughlin, Erin
    Kennedy, Kevin F.
    Alyea, Edwin P.
    Armand, Philippe
    Attar, Eyal C.
    Ballen, Karen K.
    Cutler, Corey
    Dey, Bimalangshu R.
    Koreth, John
    McAfee, Steven L.
    Spitzer, Thomas R.
    Antin, Joseph H.
    Soiffer, Robert J.
    Ho, Vincent T.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (06) : 981 - 987
  • [9] Transplantation for MDS in the Elderly: More Evidence, or More Bias?
    Cutler, Corey
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (09) : 1320 - 1321
  • [10] Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)
    Estey, Elihu
    de Lima, Marcos
    Tibes, Raoul
    Pierce, Sherry
    Kantarjian, Hagop
    Champlin, Richard
    Giralt, Sergio
    [J]. BLOOD, 2007, 109 (04) : 1395 - 1400
123